1 unchanged sentence
During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).
−Removed: 2015 Stock Plan of Moleculin Biotech, Inc.
−Removed: as amended, and forms of award agreements thereunder (incorporated by reference to exhibit 4.5 of the Form S-8 file number 333-272814)
+Added: EXHIBITS 
+Added: First Amendment to Commercial Lease Agreement for 5300 Memorial
Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
17 unchanged sentences
MOLECULIN BIOTECH, INC.
−Removed: August 10, 2023
+Added: November 13, 2023
/s/ Walter V.
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 10, 2023
+Added: November 13, 2023
/s/ Jonathan P.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.